Company registration number 13017039 (England and Wales)
AMSO HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
AMSO HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
AMSO HEALTHCARE LIMITED
BALANCE SHEET
AS AT
30 DECEMBER 2024
30 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
15,937
20,732
Current assets
Debtors
5
351,376
174,433
Cash at bank and in hand
6,875
273
358,251
174,706
Creditors: amounts falling due within one year
6
(261,154)
(224,547)
Net current assets/(liabilities)
97,097
(49,841)
Net assets/(liabilities)
113,034
(29,109)
Capital and reserves
Called up share capital
200
200
Profit and loss reserves
112,834
(29,309)
Total equity
113,034
(29,109)

For the financial year ended 30 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 10 March 2026 and are signed on its behalf by:
Dr N N Amso
Director
Company registration number 13017039 (England and Wales)
AMSO HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

Amso Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 62 Ely Road, Cardiff, Wales, CF5 2JG. The company number is 13017039.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost, and subsequently measured at cost net of depreciation.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% reducing balance
Computers
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand.

AMSO HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, and loans from fellow group companies, are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

AMSO HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2024
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
2
2
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2024
34,985
Disposals
(902)
At 30 December 2024
34,083
Depreciation and impairment
At 1 January 2024
14,253
Depreciation charged in the year
4,028
Eliminated in respect of disposals
(135)
At 30 December 2024
18,146
Carrying amount
At 30 December 2024
15,937
At 31 December 2023
20,732
AMSO HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2024
- 5 -
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
1,949
827
Amounts owed by group undertakings
324,289
141,611
Other debtors
25,138
31,995
351,376
174,433
6
Creditors: amounts falling due within one year
2024
2023
£
£
Obligations under finance leases
-
0
8,800
Trade creditors
12,766
24,732
Taxation and social security
6,891
19,521
Other creditors
223,448
162,838
Accruals and deferred income
18,049
8,656
261,154
224,547

Obligations under finance leases are secured on the assets to which they relate.

2024-12-30 2024-01-01 false false false 10 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr J L Scott Dr N N Amso 2026-03-10 13017039 2024-01-01 2024-12-30 13017039 2024-12-30 13017039 2023-12-31 13017039 core:OtherPropertyPlantEquipment 2024-12-30 13017039 core:OtherPropertyPlantEquipment 2023-12-31 13017039 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-30 13017039 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 13017039 core:CurrentFinancialInstruments 2024-12-30 13017039 core:CurrentFinancialInstruments 2023-12-31 13017039 core:ShareCapital 2024-12-30 13017039 core:ShareCapital 2023-12-31 13017039 core:RetainedEarningsAccumulatedLosses 2024-12-30 13017039 core:RetainedEarningsAccumulatedLosses 2023-12-31 13017039 bus:Director2 2024-01-01 2024-12-30 13017039 core:PlantMachinery 2024-01-01 2024-12-30 13017039 core:ComputerEquipment 2024-01-01 2024-12-30 13017039 2023-01-01 2023-12-31 13017039 core:OtherPropertyPlantEquipment 2023-12-31 13017039 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-30 13017039 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-30 13017039 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-30 13017039 bus:FRS102 2024-01-01 2024-12-30 13017039 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-30 13017039 bus:Director1 2024-01-01 2024-12-30 13017039 bus:FullAccounts 2024-01-01 2024-12-30 xbrli:pure xbrli:shares iso4217:GBP